The impact of taurine-and beta-alanine-supplemented diets on behavioral and neurochemical parameters in mice: Antidepressant versus anxiolytic-like effects

Amino Acids

Volumn 39, Issue 2, 2010, Pages 427-434

  Murakami, Tatsuro ^a   Furuse, Mitsuhiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Amino acids; Beta alanine; Brain derived neurotrophic factor; Elevated plus maze test; Forced swimming test; Taurine

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; AMINO ACID; ARGININE; BETA ALANINE; BRAIN DERIVED NEUROTROPHIC FACTOR; CARNOSINE; MONOAMINE; SEROTONIN; TAURINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DIET SUPPLEMENTATION; FOOD INTAKE; FORCED SWIMMING TEST; HIPPOCAMPUS; HYPOTHALAMUS; LOCOMOTION; MALE; MAZE TEST; MOUSE; NEUROTRANSMISSION; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN FUNCTION; TRANQUILIZING ACTIVITY; ANIMAL; DRUG EFFECTS; DRUG THERAPY; INSTITUTE FOR CANCER RESEARCH MOUSE; MENTAL STRESS; METABOLISM;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ARGININE; BEHAVIOR, ANIMAL; BETA-ALANINE; BRAIN-DERIVED NEUROTROPHIC FACTOR; CARNOSINE; CEREBRAL CORTEX; DIETARY SUPPLEMENTS; HIPPOCAMPUS; HYDROXYINDOLEACETIC ACID; HYPOTHALAMUS; MALE; MICE; MICE, INBRED ICR; STRESS, PSYCHOLOGICAL; TAURINE;

ANIMALIA; MUS;

EID: 84755161474     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-009-0458-x     Document Type: Article

References (32)

1. Abe H (2000) Role of histidine-related compounds as intracellular proton buffering constituents in vertebrate muscle. Biochemistry 65:757-765
2. Aley KO, Kulkarni SK (1989) GABA-mediated modification of despair behavior in mice. Naunyn Schmiedebergs Arch Pharmacol 339:306-311
3. Birdsall TC (1998) Therapeutic applications of taurine. Altern Med Rev 3:128-136
4. Cao BJ, Rodgers RJ (1997) Comparative behavioural profiles of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in the murine elevated plus-maze. Neuropharmacology 36:1089-1097
5. Castrén E (2004) Neurotrophic effects of antidepressant drugs. Curr Opin Pharmacol 4:58-64
6. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT (2001) Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50:260-265
7. Chen SW, Kong WX, Zhang YJ, Li YL, Mi XJ, Mu XS (2004) Possible anxiolytic effects of taurine in the mouse elevated plusmaze. Life Sci 75:1503-1511
8. Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ, Herrera DG, Toth M, Yang C, McEwen BS, Hempstead BL, Lee FS (2006) Genetic variant BDNF (Val66Met) polymorphism alters anxietyrelated behavior. Science 314:140-143
9. Cirulli F, Berry A, Chiarotti F, Alleva E (2004) Intrahippocampal administration of BDNF in adult rats affects short-term behavioral plasticity in the Morris water maze and performance in the elevated plus-maze. Hippocampus 14:802-807
10. da Silva GD, Matteussi AS, dos Santos AR, Calixto JB, Rodrigues AL (2000) Evidence for dual effects of nitric oxide in the forced swimming test and in the tail suspension test in mice. Neuroreport 11:3699-3702
11. Engelmann M, Wolf G, Horn TF (2002) Release patterns of excitatory and inhibitory amino acids within the hypothalamic supraoptic nucleus in response to direct nitric oxide administration during forced swimming in rats. Neurosci Lett 324:252-254
12. Handley SL, McBlane JW (1993) 5HT drugs in animal models of anxiety. Psychopharmacology (Berl) 112:13-20
13. Hussy N, Deleuze C, Desarménien MG, Moos FC (2000) Osmotic regulation of neuronal activity: a new role for taurine and glial cells in a hypothalamic neuroendocrine structure. Prog Neurobiol 62:113-134
14. Inan SY, Yalcin I, Aksu F (2004) Dual effects of nitric oxide in the mouse forced swimming test: possible contribution of nitric oxide-mediated serotonin release and potassium channel modulation. Pharmacol Biochem Behav 77:457-464
15. Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G (2005) Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 57:1068-1072
16. Karolewicz B, Paul IA (2001) Group housing of mice increases immobility and antidepressant sensitivity in the forced swim and tail suspension tests. Eur J Pharmacol 415:197-201
17. Kohen R, Yamamoto Y, Cundy KC, Ames BN (1988) Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain. Proc Natl Acad Sci USA 85:3175-3179
18. Kong WX, Chen SW, Li YL, Zhang YJ, Wang R, Min L, Mi X (2006) Effects of taurine on rat behaviors in three anxiety models. Pharmacol Biochem Behav 83:271-276
19. Murakami T, Yamane H, Tomonaga S, Furuse M (2009) Forced swimming and imipramine modify plasma and brain amino acid concentrations in mice. Eur J Pharmacol 602:73-77
20. Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349:1498-1504
21. Oja SS, Saransaari P (1996) Taurine as osmoregulator and neuromodulator in the brain. Metab Brain Dis 11:153-164
22. Parildar-Karpuzoǧlu H, Doǧru-Abbasoǧlu S, Balkan J, Aykaç-Toker G, Uysal M (2007) Decreases in taurine levels induced by betaalanine treatment did not affect the susceptibility of tissues to lipid peroxidation. Amino Acids 32:115-119
23. Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327-336
24. Saransaari P, Oja SS (2000) Taurine and neural cell damage. Amino Acids 19:509-526
25. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, Nakazato M, Watanabe H, Shinoda N, Okada S, Iyo M (2003) Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54:70-75 (Pubitemid 36776725)
26. Singewald N, Ebner K, Landgraf R, Wotjak CT, Engelmann M (1999) Vasopressin selectively modulates the release of taurine within the septum of the rat brain. Neurosci Lett 277:68-70
27. --dependent high affinity taurine transporter. Biochim Biophys Acta 1464:219-230
28. Tomonaga S, Tachibana T, Takagi T, Saito ES, Zhang R, Denbow DM, Furuse M (2004) Effect of central administration of carnosine and its constituents on behaviors in chicks. Brain Res Bull 63:75-82 (Pubitemid 38581942)
29. Tomonaga S, Tachibana T, Takahashi H, Sato M, Denbow DM, Furuse M (2005) Nitric oxide involves in carnosine-induced hyperactivity in chicks. Eur J Pharmacol 524:84-88
30. Whirley BK, Einat H (2008) Taurine trials in animal models offer no support for anxiolytic, antidepressant or stimulant effects. Isr J Psychiatry Relat Sci 45:11-18
31. Wong PT, Ong YP (2001) Acute antidepressant-like and antianxietylike effects of tryptophan in mice. Pharmacology 62:151-156
32. Wu FS, Gibbs TT, Farb DH (1993) Dual activation of GABAA and glycine receptors by beta-alanine: inverse modulation by progesterone and 5 alpha-pregnan-3 alpha-ol-20-one. Eur J Pharmacol 246:239-246